Susquehanna raised their price target on Haemonetics Corporation (NYSE: HAE) to $65 per share, while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE